- Home
- HSCS vs YCBD Comparison
HSCS vs YCBD Comparison
Compare HSCS & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- YCBD
- Stock Information
- Founded
- HSCS 2007
- YCBD 2015
- Country
- HSCS United States
- YCBD United States
- Employees
- HSCS N/A
- YCBD N/A
- Industry
- HSCS Medical Specialities
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- YCBD Health Care
- Exchange
- HSCS Nasdaq
- YCBD Nasdaq
- Market Cap
- HSCS 8.7M
- YCBD 7.8M
- IPO Year
- HSCS 2022
- YCBD N/A
- Fundamental
- Price
- HSCS $3.46
- YCBD $0.69
- Analyst Decision
- HSCS Strong Buy
- YCBD Strong Buy
- Analyst Count
- HSCS 2
- YCBD 1
- Target Price
- HSCS $13.00
- YCBD $2.00
- AVG Volume (30 Days)
- HSCS 87.4K
- YCBD 98.5K
- Earning Date
- HSCS 09-11-2025
- YCBD 08-14-2025
- Dividend Yield
- HSCS N/A
- YCBD N/A
- EPS Growth
- HSCS N/A
- YCBD N/A
- EPS
- HSCS N/A
- YCBD N/A
- Revenue
- HSCS $6,250.00
- YCBD $19,026,064.00
- Revenue This Year
- HSCS $13,968.97
- YCBD $0.37
- Revenue Next Year
- HSCS $166.67
- YCBD $4.95
- P/E Ratio
- HSCS N/A
- YCBD N/A
- Revenue Growth
- HSCS N/A
- YCBD N/A
- 52 Week Low
- HSCS $2.52
- YCBD $0.59
- 52 Week High
- HSCS $6.47
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- HSCS 50.77
- YCBD 43.27
- Support Level
- HSCS $3.00
- YCBD $0.68
- Resistance Level
- HSCS $3.70
- YCBD $0.75
- Average True Range (ATR)
- HSCS 0.21
- YCBD 0.05
- MACD
- HSCS 0.02
- YCBD 0.00
- Stochastic Oscillator
- HSCS 65.71
- YCBD 16.54
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.